This workshop was held on May 13-14, 2024 and brought together senior leaders/experts, junior investigators, and NCI staff who concentrate their research on Myelodysplastic Syndromes (MDS).
There are more than 10,000 new cases of MDS diagnosed in the U.S. every year. These blood cancers remain difficult to treat due to vast differences in the patient population including great genetic diversity, complicated clinical presentation with similarities to several overlap syndromes, and lack of highly effective and long-lasting treatments.
Presenters evaluated the current state of basic, preclinical and clinical sciences in this area, as well as identified key challenges and opportunities to foster MDS research and care.
Documents from the Workshop
- Agenda
- Participant List
- Speaker Bios
- National MDS Natural History Study: Information and resources from a national clinical trial that aims to improve the way MDS is diagnosed and how it is treated.
Social Media Related to the Workshop
Social media posts related to the workshop can be found using #Research4MDS.
DCB Contact for the Workshop
For additional information about the MDS Workshop, please contact Dr. Margaret (Gosia) Klauzinska.